The Brain Stimulation and Physical Therapy Study
The Feasibility and Effectiveness of Combining Non-invasive Brain Stimulation and Physical Therapy to Improve Gait and Balance in Older Adults at Risk of Falling
1 other identifier
interventional
10
1 country
1
Brief Summary
This pilot work will determine the feasibility of tDCS intervention as an effective adjunct intervention to PT aimed at improving gait, balance, and mobility in older adults at risk of falling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 22, 2019
CompletedFirst Submitted
Initial submission to the registry
November 26, 2019
CompletedFirst Posted
Study publicly available on registry
November 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedSeptember 5, 2021
September 1, 2021
1.5 years
November 26, 2019
September 1, 2021
Conditions
Outcome Measures
Primary Outcomes (7)
Screening to enrollment ratio (%, 0-100, higher ratio means a better outcome)
The number of screenings needed to enroll one participant
The whole data collection period (~ 6 months for the whole study)
Intervention adherence rate (%, 0-100, higher ratio means a better outcome)
Number of tDCS sessions completed
The whole data collection period (~ 6 months for the whole study)
Adherence rate (%, 0-100, higher ratio means a better outcome)
The portion of enrolled participants who complete and adhere to the intervention who complete and adhere to the intervention
The whole data collection period (~ 6 months for the whole study)
Side effects
The number, type, severity and duration of reported side effects
The whole data collection period (~ 6 months for the whole study)
Change from baseline in the dual task cost to gait speed (reduced dual task cost after intervention means a better outcome)
The change from baseline in the degree to which performing a secondary cognitive task diminishes gait speed
Before and after the intervention (~ 6 weeks per participant)
Change from baseline in the dual task cost to standing postural sway speed (reduced dual task cost after intervention means a better outcome)
The change from baseline in the degree to which performing a secondary cognitive task diminishes the control of standing posture.
Before and after the intervention (~ 6 weeks per participant)
Change from baseline in Trail Making Test B - A (reduced time after intervention means a better outcome)
The change from baseline in cognitive executive function
Before and after the intervention (~ 6 weeks per participant)
Secondary Outcomes (5)
Change from baseline in gait speed (increased value after intervention means a better outcome)
Before and after the intervention (~ 6 weeks per participant)
Change from baseline in gait variability (reduced value after intervention means a better outcome)
Before and after the intervention (~ 6 weeks per participant)
Change from baseline in gradual-onset continuous performance test (gradCPT) ( increased accuracy after intervention means a better outcome)
Before and after the intervention (~ 6 weeks per participant)
Change from baseline in Timed Up-and-Go (TUG) (reduced time after intervention means a better outcome)
Before and after the intervention (~ 6 weeks per participant)
Change from baseline in Montreal Cognitive Assessment (MoCA) total score (increased score after intervention means a better outcome)
Before and after the intervention (~ 6 weeks per participant)
Study Arms (2)
Real tDCS and Physical Therapy
EXPERIMENTALThis arm combines tDCS and Physical Therapy intervention. The real tDCS will be delivered before each physical therapy visit for up to 10 combined sessions. The tDCS montage was designed to target the left dorsal lateral prefrontal cortex (DLPFC) for around 20 minutes. The direct current delivered by any electrode will not exceed 2.0 milliamp(mA) and the total amount of current from all electrodes will not exceed 4 mA.
Sham stimulation and Physical Therapy
SHAM COMPARATORThis arm combines sham stimulation and Physical Therapy intervention. The sham stimulation will be delivered before each physical therapy visit for up to 10 combined sessions. We will use an active sham stimulation in which very low-level currents (0.5 mA total) will be transferred between electrodes in close proximity on the scalp throughout the entire 20-minute session. This montage was designed to deliver currents not significantly influence their cortical tissue, but still, mimic the cutaneous sensations induced by tDCS over the same brain site (i.e. left DLPFC).
Interventions
The participant will receive 20-minute sessions of real tDCS before each physical therapy visit for up to 10 combined sessions, over approximately 6 weeks.
The participant will receive 20-minute sessions of sham stimulation before each physical therapy visit for up to 10 combined sessions, over approximately 6 weeks.
Eligibility Criteria
You may qualify if:
- Ages 65 years old and above
- Admitted to Physical Therapy for gait and balance training due to the high risk of falls
You may not qualify if:
- Inability to stand or walk unassisted for 60 seconds
- Severe cognitive impairment defined as a Montreal Cognitive Assessment (MoCA) score \< 18
- Any unstable medical condition
- Any unstable psychiatric co-morbidity including major depressive disorder, schizophrenia or psychosis
- Active cancer for which chemo/radiation therapy id being received
- Significant vision and hearing problems that cannot be corrected with visual and hearing aids
- Contraindications to tDCS, including seizure within the past two years, use of neuro-active drugs, the risk of metal objects in the brain, implanted medical devices, or the presence of dermatological conditions such as eczema on the scalp.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hebrew Rehabilitation Center
Boston, Massachusetts, 02131, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
On-Yee Lo, PhD
Hebrew Rehabilitation Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2019
First Posted
November 29, 2019
Study Start
October 22, 2019
Primary Completion
May 1, 2021
Study Completion
May 1, 2021
Last Updated
September 5, 2021
Record last verified: 2021-09